Abiopharma

🔍 DIXTON GRANT MICHAEL (Executive)

Company: General Motors Co (GM)

Report Date: 2026-07-30

Detailed Transactions and Holdings:

• Acquired 79,132 shares of Common Stock (Direct)
  Date: 2026-07-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 130,048.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 35,056 shares of Common Stock at $88.4 per share (Direct)
  Date: 2026-07-30 | Code: F | equity_swap_involved: 0 | shares_owned_after: 94,992.00 | transaction_form_type: 4
• Sold 40,000 shares of Common Stock at $88.44 per share (Direct)
  Date: 2026-08-03 | Code: S | equity_swap_involved: 0 | shares_owned_after: 54,992.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 79,132 shares of Restricted Stock Units (Derivative)
  Date: 2026-07-30 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F4, F5

Footnotes:

• F1: Each Restricted Stock Unit ("RSU") converts into common stock on a one-for-one basis.
• F2: The price in Column 4 is the weighted average selling price of the shares. The shares were sold in multiple transactions at prices from $87.31 to $90.04, inclusive. The Reporting Person undertakes to provide to the SEC, GM and any security holder, upon request, full information regarding the number of shares sold at each price point within the ranges set forth in this footnote.
• F3: The RSUs do not have a conversion or exercise price. Upon vesting, they will be settled in shares of the Company's common stock on a one-for-basis.
• F4: Of these RSUs, one-half vested on July 30, 2025, and the remaining one-half vested on July 30, 2026.
• F5: The RSUs do not have a date on which they will expire. They have vested and settled on July 30, 2026.